HCAT Health Catalyst Inc
Price (delayed)
$3.9
Market cap
$273.82M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$426.44M
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage
Highlights
HCAT's EPS is up by 45% year-on-year and by 14% since the previous quarter
The net income has grown by 41% YoY and by 12% from the previous quarter
Health Catalyst's quick ratio has plunged by 68% YoY
The company's debt has surged by 62% YoY and by 10% QoQ
Key stats
What are the main financial stats of HCAT
Market
Valuations
Earnings
Shares outstanding
70.21M
Market cap
$273.82M
Enterprise value
$426.44M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.65
Price to sales (P/S)
0.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.39
Revenue
$306.58M
Gross profit
$140.78M
Operating income
-$69.81M
Net income
-$69.5M
EBIT
-$69.81M
EBITDA
-$25.69M
Free cash flow
-$1.32M
Per share
Balance sheet
Liquidity
EPS
-$1.15
EPS diluted
-$1.15
Free cash flow per share
-$0.02
Book value per share
$6
Revenue per share
$5.09
TBVPS
$8.53
Total assets
$858.93M
Total liabilities
$493.72M
Debt
$402.27M
Equity
$365.21M
Working capital
$139.8M
Debt to equity
1.1
Current ratio
1.43
Quick ratio
1.38
Net debt/EBITDA
-5.94
Margins
Efficiency
Dividend
EBITDA margin
-8.4%
Gross margin
45.9%
Net margin
-22.7%
Operating margin
-22.8%
Return on assets
-9.1%
Return on equity
-19.4%
Return on invested capital
-25.5%
Return on capital employed
-13.1%
Return on sales
-22.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCAT stock price
How has the Health Catalyst stock price performed over time
Intraday
6.56%
1 week
4%
1 month
-11.56%
1 year
-30.36%
YTD
-44.84%
QTD
-13.91%
Financial performance
How have Health Catalyst's revenue and profit performed over time
Revenue
$306.58M
Gross profit
$140.78M
Operating income
-$69.81M
Net income
-$69.5M
Gross margin
45.9%
Net margin
-22.7%
The operating margin rose by 47% YoY and by 19% QoQ
The operating income is up by 45% year-on-year and by 18% since the previous quarter
The company's net margin rose by 43% YoY and by 13% QoQ
The net income has grown by 41% YoY and by 12% from the previous quarter
Growth
What is Health Catalyst's growth rate over time
Valuation
What is Health Catalyst stock price valuation
P/E
N/A
P/B
0.65
P/S
0.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.39
HCAT's EPS is up by 45% year-on-year and by 14% since the previous quarter
HCAT's price to book (P/B) is 77% lower than its 5-year quarterly average of 2.8 and 46% lower than its last 4 quarters average of 1.2
The company's equity rose by 2.9% QoQ
The stock's price to sales (P/S) is 84% less than its 5-year quarterly average of 4.8 and 45% less than its last 4 quarters average of 1.4
The company's revenue rose by 3.6% YoY
Efficiency
How efficient is Health Catalyst business performance
HCAT's ROS is up by 47% year-on-year and by 14% since the previous quarter
Health Catalyst's return on assets has increased by 46% YoY and by 17% QoQ
HCAT's return on equity is up by 40% year-on-year and by 12% since the previous quarter
Dividends
What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCAT.
Financial health
How did Health Catalyst financials performed over time
HCAT's total assets is 74% greater than its total liabilities
Health Catalyst's quick ratio has plunged by 68% YoY
The current ratio has plunged by 68% YoY
The company's debt is 10% higher than its equity
The company's debt has surged by 62% YoY and by 10% QoQ
The debt to equity has soared by 62% year-on-year and by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.